logo

Indian News

Share SHARE

Pharma-071717.jpg Today's Daily Dose brings you news about Aeterna's leadership change; Aptevo's agreement with Alligator Bioscience; Amgen's regulatory catalyst related to migraine med Aimovig; Diffusion Pharma's milestone achievement; Incyte's progress in GRAVITAS-301 study and FDA's tentative nod for Merck.

July20-072017.jpg The following are some of the biotech stocks that made their way onto the Day's Gainers & Losers' list of July 20, 2017.

ADB-072017.jpg The Asian Development Bank raised its developing Asia's growth outlook citing stronger-than-expected export demand. In its Asian Development Outlook, released Thursday, the bank upgraded developing Asia's growth outlook for 2017 to 5.9 percent from 5.7 percent.

Pharma-072017.jpg Today's Daily Dose brings you news about Aerie Pharma's Mercury-1 study results; reduction in size of Alimera's post-marketing study of ILUVIEN; ContraFect's stock offering; spin-off of Immune Pharma's subsidiary; Sarepta's stellar Q2 results and Theravance's COPD trial results.

July19-071917.jpg The following are some of the biotech stocks that made their way onto the Day's Gainers & Losers' list of July 19, 2017.

pharma-071917.jpg Today's Daily Dose brings you news about Aeterna's upcoming make or break event; Aldeyra's clinical trial catalyst of this quarter; FDA approval of Gilead's HCV drug; Inovio's proposed stock offering; Nektar's oral Human Abuse Potential study of NKTR-181 and Vertex Pharma's cystic fibrosis trial results.

July18-071817.jpg The following are some of the biotech stocks that made their way onto the Day's Gainers & Losers' list of July 18, 2017.

pharma-071817.jpg Today's Daily Dose brings you news about Anika's preliminary second quarter revenue; Asterias' progress in SCiStar trial; CymaBay's encouraging results from PBC trial; EDAP's Focal One update; Ligand's expanded license relationship with Amgen; Paratek's encouraging results from OASIS-2 study and FDA approval of Puma's breast cancer drug.

July17-071717.jpg Here's why ACRX, QDEL and IPXL soared while RDUS and SUPN tanked.

MICRON-071717.jpg Shares of Micron Technology Inc. (MU) have gained 45% so far this year, topping the 17% return for the Nasdaq Composite Index.

Follow RTT